If you typed ILS Clinical Research into a search box, you are probably building a CRO or site shortlist for Mexico. This article uses only what is public about ILS Clinical Research (ClinicalTrials.gov NCT03460743) and compares it with bioaccess®, the First-in-Human CRO for medical devices in Latin America since 2010. It is a practitioner comparison, not a teardown.
What ILS Clinical Research publishes
ILS Clinical Research is a Mexican clinical research organization. It is listed as a collaborator, alongside EPIC Research CRO and Q Square Solutions, on a Laboratorios Liomont quadrivalent influenza vaccine study (NCT03460743). ILS Clinical Research S.A.C. also appears in the Peru INS register of research organizations.
ILS Clinical Research vs bioaccess®
| Dimension | ILS Clinical Research | bioaccess® |
|---|---|---|
| Core focus | Drug and vaccine clinical research, Mexico | First-in-human and early feasibility studies for medical devices |
| Geography | See provider site | Latin America, since 2010 |
| Device FIH track record | No named device first-in-human study found on the public pages reviewed | Published case studies on bioaccessla.com |
| After the trial | See provider site | Live multi-country sanitary registration and in-country holder service |
Where each one fits
If you need a Mexican partner with drug and vaccine study experience, ILS Clinical Research’s public record matches.
If the job is a first-in-human or early feasibility study for a medical device, bioaccess® is a specialist built for exactly that, running device studies in Latin America since 2010. When the study ends, the same company can register and hold the device across the region through its market access service. Ask any CRO or site on your list, including ILS Clinical Research, for a named or de-identified device first-in-human study: device class, implant or not, number of patients, ISO 14155 monitoring plan and how the data was used in an FDA file.
For the local regulatory path, see CRO in Mexico. Other Latin American CROs are compared in the guide to first-in-human device CROs in Latin America and on the bioaccess® compare hub.
Ready to compare a proposal? Request a first-in-human study proposal.
Facts from the ILS Clinical Research public pages and registries linked above, reviewed for bioaccess® competitive research (Oct 2026). Claims are theirs. No invented sponsors, prices or contacts.